Zydus Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?
ZYDUS PHARMS has two hundred and seventy approved drugs.
There are twenty-three tentative approvals on ZYDUS PHARMS drugs.
Summary for Zydus Pharms
| US Patents: | 0 |
| Tradenames: | 235 |
| Ingredients: | 226 |
| NDAs: | 270 |
Drugs and US Patents for Zydus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 208948-001 | Jul 17, 2018 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Pharms Usa Inc | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | INJECTABLE;INJECTION | 091534-001 | Feb 22, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Zydus Pharms | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203162-001 | Aug 31, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
